Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on Resignation of FDA Commissioner…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE…
BIO Launches “The Fight of Our Lives,” a National…
WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of ​​The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them…
BIO Statement on the Section 232 Pharmaceutical…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on Section 232 Pharmaceutical Proclamation.“A thriving American biotechnology ecosystem is essential to…
All Press Releases
  • Show All
Search
Results
Event Tags
July 23, 2019
Washington, DC (July 23, 2019) – Following the release of the Senate Finance Committee’s drug pricing proposal, Tom DiLenge, the Biotechnology Innovation Organization’s President of Advocacy, Law & Public Policy Division issued the…
July 23, 2019
Washington, DC (July 23, 2019) – Today, legislation that would significantly improve the ability of emerging biotechnology companies to focus their investor capital on science and biomedical innovation was introduced in the House of…
July 11, 2019
As presidential candidates trek across the Hawkeye State and campaign on addressing society’s most pressing challenges, biotech innovators wrapped up four days of showcasing the scientific solutions to climate change, hunger, pollution and energy…
July 11, 2019
BIO’s President and CEO Jim Greenwood issued the following statement after it was reported that the Trump administration is withdrawing its proposed rebate rule that would have required savings from drugmakers' rebates be passed along to…
July 10, 2019
Strong patent rights are essential to finance the revolution in biotechnology discoveries from the lab to the patient, farmer, and consumer
July 8, 2019
Washington, D.C. (July 5, 2019) – The Biotechnology Innovation Organization (BIO) released the following statement on the U.S. Environmental Protection Agency’s (EPA) proposed Renewable Fuel Standard (RFS) volumes for 2020. “EPA’s proposal to…
July 2, 2019
Washington, D.C. (July 2, 2019) – The Biotechnology Innovation Organization (BIO) announced today that Stephanie Batchelor has been named BIO’s vice president for its industrial & environmental (I&E) section.
July 1, 2019
Washington, DC – (July 1, 2019) – The Biotechnology Innovation Organization (BIO) today announced winners of the Start-up Stadium competition held last month at the BIO International Convention in Philadelphia. During five sessions over three days,…
June 27, 2019
NEW YORK – June 25, 2019 – Executive Women in Bio (EWIB), a committee comprised of senior leaders in the life sciences and biopharma operating within the national non-profit organization, Women In Bio (WIB), is pleased to announce a new partnership…
June 13, 2019
The Biotechnology Innovation Organization (BIO) today thanked Senators Chris Coons (D-Del.) and Jerry Moran (R-Kan.) and Representatives Mike Thompson (D-Calif.) and Ron Estes (R-Kan.) for introducing the Financing Our Energy Future Act.